By Drug Target Review2024-02-23T16:00:50
Researchers discovered that NPTX2 protein accumulated in cells containing abnormal TDP-43 in FTD and ALS patients.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2023-02-23T14:02:18
Sponsored by bit.bio
2024-01-09T09:30:19
Sponsored by Sartorius
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud